ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Montréal, QC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Endometrial Cancer
Non-Small-Cell Lung Carcinoma
Neoplasm Metastasis

Breast Cancer trials near Montréal, QC, CAN:

Breast Cancer Plasma Adjuvant Intra-operative Treatment (Breast Cancer PAINT)

an ionized gas) on the tumor bed after the removal of the tumor in breast cancer patients. The main questions it aims to answer are ...

Begins enrollment in 1 month
Breast Cancer
Device: Convertible Plasma Jet
Centre hospitalier de l'Université de Montréal (CHUM)

Montréal, Quebec, Canada

DESTINY-Breast07 will investigate the safety, tolerability, and anti-tumour activity of trastuzumab deruxtecan (T-DXd) in combination with o ...

Active, not recruiting
Metastatic Breast Cancer
Drug: Tucatinib
Drug: Durvalumab

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Montreal, Quebec, Canada and 71 other locations

A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....

Enrolling
Advanced Breast Cancer
Drug: Fulvestrant
Drug: ARV-471

Phase 3

Pfizer
Pfizer

St-Jerome, Quebec, Canada and 324 other locations

The ZetaFuse™ Bone Graft is indicated for patients with destructive, lytic lesions due to metastatic breast cancer to bone, with or...

Enrolling
Metastatic Breast Cancer in the Spine
Device: ZetaFuse™ Bone Graft
Zetagen Therapeutics

Montréal, Quebec, Canada and 1 other location

postmenopausal women with locally advanced or metastatic ER+/HER2- breast cancer with an acquired ESR1 mutation and who have diseas...

Active, not recruiting
Locally Advanced or Metastatic Breast Cancer
Drug: Lasofoxifene
Drug: Fulvestrant

Phase 2

Sermonix Pharmaceuticals

Montréal, Quebec, Canada and 50 other locations

look at the efficacy and safety of trastuzumab deruxtecan (T-DXd) in a neoadjuvant setting, in high-risk, HER2-positive early non-metastatic breast...

Active, not recruiting
HER2-positive Early Breast Cancer
Breast Cancer
Drug: Pertuzumab
Drug: Paclitaxel

Phase 3

AstraZeneca
AstraZeneca

Montreal, Canada and 147 other locations

medicines for the potential treatment of advanced or metastatic breast cancer.This study is seeking participants who have breast...

Enrolling
Breast Cancer
Drug: Abemaciclib
Drug: ARV-471

Phase 1, Phase 2

Pfizer
Pfizer

Montreal, Quebec, Canada and 41 other locations

Locations recently updated

medicines for the potential treatment of advanced or metastatic breast cancer.This study is seeking participants who have breast...

Enrolling
Breast Cancer
Drug: ARV-471
Drug: Ribociclib

Phase 1, Phase 2

Pfizer
Pfizer

Montreal, Quebec, Canada and 43 other locations

with inoperable or metastatic HR-positive, HER2- negative breast cancer who have been treated with one or two prior lines of...

Active, not recruiting
Breast Cancer
Drug: Vinorelbine
Drug: Eribulin

Phase 3

AstraZeneca
AstraZeneca

Montreal, Quebec, Canada and 166 other locations

how treatment with Fulvestrant (FASLODEX) or Anastrozole (ARIMIDEX) effects disease progression for women with locally advanced or metastatic breast...

Active, not recruiting
Hormone Receptor Positive Breast Cancer
Drug: faslodex dummy
Drug: arimidex dummy

Phase 3

AstraZeneca
AstraZeneca

Montreal, Quebec, Canada and 118 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems